Bayer wins its first Roundup jury verdict in case of kid’s most cancers


Oct 5 (Reuters) – Bayer AG received its first trial over claims its Roundup weedkiller causes most cancers after a California jury discovered that the herbicide was not a considerable trigger of a kid’s uncommon type of non-Hodgkin’s lymphoma, the corporate mentioned on Tuesday.

Destiny Clark alleged that her son Ezra developed Burkitt’s lymphoma after he was uncovered to Roundup which she sprayed on weeds on the household residence.

Clark sued Monsanto, which is owned by Bayer (BAYGn.DE), for failing to warn her of the most cancers dangers of utilizing Roundup.

The verdict is the fourth involving Roundup and the primary within the firm’s favor.

Roundup-related lawsuits have dogged Bayer because it acquired the model as a part of its $63 billion buy of agricultural seeds and pesticides maker Monsanto in 2018.

Bayer mentioned in an announcement the decision was per a long time of science and analysis exhibiting the protection of glyphosate, the principle ingredient in Roundup.

“While we have great sympathy for Ezra Clark and his family, the jury carefully considered the science applicable to this case and determined that Roundup was not the cause of his illness,” the corporate mentioned.

An legal professional for Clark mentioned they’ll take into account an enchantment.

“We’re disappointed for the boy and his family,” mentioned Fletcher Trammel. “We have multiple Roundup cases set across the country over the next year and look forward to trying them.”

Two of the opposite three verdicts are nonetheless being appealed by Bayer, together with one the corporate hopes will probably be thought of by the U.S. Supreme Court, the place a ruling for Bayer might successfully finish the Roundup instances. learn extra

The firm has settled round 96,000 Roundup instances of about 125,000.

In May, a federal decide rejected Bayer’s plan to resolve future instances, which might have supplied compensation however restricted the flexibility of people to sue. learn extra

Reporting by Tom Hals in Wilmington, Delaware; Editing by Noeleen Walder and Richard Pullin

Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany. REUTERS/Wolfgang Rattay

Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

Bayer unit Monsanto Co's Roundup is shown for sale in Encinitas, California, U.S., June 26, 2017.  REUTERS/Mike Blake/File Photo